Crystal Adaminsider trades
In SEC Form 4 filings, Crystal Adam is listed as President, R&D of Tango Therapeutics, Inc. (TNGX). In the last 90 days, Crystal Adam sold $1.26M of Tango Therapeutics, Inc. (TNGX) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TNGXTango Therapeutics, Inc. | President, R&D | 7 | Oct 5 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TNGXTango Therapeutics, Inc. | Oct 1 | Oct 5 | M | 27,000 | $5.20 | $140,400 | 142,743 | Yes | Form 4 |
| TNGXTango Therapeutics, Inc. | Oct 1 | Oct 5 | S | 26,400 | $24.45 | Sale −$645,604 | 116,343 | Yes | Form 4 |
| TNGXTango Therapeutics, Inc. | Oct 1 | Oct 5 | S | 600 | $25.32 | Sale −$15,192 | 115,743 | Yes | Form 4 |
| TNGXTango Therapeutics, Inc. | Oct 1 | Oct 5 | M · derivative | 27,000 | $5.20 | $140,400 | 233,040 | Yes | Form 4 |
| TNGXTango Therapeutics, Inc. | Sep 1 | Sep 3 | M | 27,000 | $5.20 | $140,400 | 142,743 | Yes | Form 4 |
| TNGXTango Therapeutics, Inc. | Sep 1 | Sep 3 | S | 27,000 | $22.37 | Sale −$603,909 | 115,743 | Yes | Form 4 |
| TNGXTango Therapeutics, Inc. | Sep 1 | Sep 3 | M · derivative | 27,000 | $5.20 | $140,400 | 260,040 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.